Transvaginal Mesh Litigation Moves Forward as J&J Faces First Trial in New Jersey, Parker Waichman LLP Reports

Share Article

Parker Waichman LLP reports that Johnson & Johnson and its subsidiary Ethicon are facing its first trial over transvaginal mesh implants used to treat pelvic organ prolapse and stress urinary incontinence. According to the U.S. Food and Drug Administration (FDA), complications linked to the device, including mesh erosion, organ perforation and urinary problems, are “not rare”; furthermore, the agency has stated that there is no evidence showing that the mesh is superior to non-mesh methods for treating pelvic organ prolapse.

News Image
Women suing over transvaginal mesh allege that the devices caused organ perforation, pain, scarring and nerve damage, Bloomberg reports.

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that Ethicon and parent company Johnson & Johnson are facing the first trial over transvaginal mesh implants. Jury selection began on Monday January 7th and the trial is scheduled to last over a month. According to Bloomberg News, the case going to trial is one of 1,800 filed in state court in New Jersey. Women suing over transvaginal mesh allege that the devices caused organ perforation, pain, scarring and nerve damage, Bloomberg reports.

Transvaginal mesh implants are used to reinforce the strength of pelvic muscles, and are approved to treat pelvic organ prolapse and stress urinary incontinence. A number of women, however, have filed lawsuits alleging that these devices are unsafe and cause severe injuries. Parker Waichman LLP is representing a number of women in personal injury lawsuits relating to the transvaginal mesh. The firm filed one such case on December 27th in the U.S. District Court for the Southern District of West Virginia, Charleston Division (Case 2:12-cv-09722). It is part of the multidistrict litigation known as In Re: Ethicon Inc., Pelvic Repair System Products Liability Litigation (MDL No.2327).

According to the U.S. Food and Drug Administration (FDA), the most common adverse events linked to transvaginal mesh implants include:

  •     Mesh erosion through the vagina (also called exposure, extrusion, protrusion)
  •     Pain
  •     Infection
  •     Bleeding
  •     Pain during sexual intercourse (dyapareunia)
  •     Organ perforation
  •     Urinary problems

The FDA warned that such complications are “not rare” and cautioned that there is little evidence showing that transvaginal mesh implants offer any benefits over non-mesh methods for treating pelvic organ prolapse.

Parker Waichman LLP continues to offer free lawsuit consultations to victims of transvaginal mesh injuries. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Parker Waichman LLP
1-800-529-4636
Email >
Follow us on
Visit website